(Q43944835)

English

Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

author name string

N Shirai

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

T Furuta

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

F Xiao

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

M Kajimura

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

H Hanai

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

K Ohashi

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

T Ishizaki

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

837-846

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Review article: the pharmacology of rabeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Nocturnal Recovery of Gastric Acid Secretion With Twice-Daily Dosing of Proton Pump Inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Current trends in the pharmacotherapy for peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Pharmacological aspects of acid secretion

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Effect of food on H2-receptor blockade in normal subjects and duodenal ulcer patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

A simple method for the quantification of famotidine in human plasma and urine by paired-ion high performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Circadian rhythm of gastric acid secretion in men with active duodenal ulcer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

The physiology of gastric acid secretion

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

The relation of plasma gastrin to the circadian rhythm of gastric acid secretion in man.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Patterns of acid reflux in complicated oesophagitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01229.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2002.01229.X

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43944835&oldid=2104562926"